Skip to main content
GutCited

Fructooligosaccharides (FOS) für Chronic Constipation

C

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Fazit

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None vs.: None Outcome: gut health outcomes including microbiota modulation and SCFA … Wirkung: None None

Population: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None vs.: Placebo Outcome: Weekly spontaneous bowel movements Wirkung: 4.94 vs 3.00 (P<0.001) P<0.001

Population: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g vs.: None Outcome: Constipation symptoms Wirkung: None P < 0.05

Population: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g vs.: Placebo Outcome: Constipation symptoms Wirkung: None None

Population: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None vs.: None Outcome: Constipation symptoms Wirkung: OR: 10.36 p < 0.00001

Population: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None vs.: Placebo Outcome: Constipation symptoms Wirkung: None None

Population: Constipation patients

Key Statistics

4

Studien

350

Teilnehmer

Positive

C

Bewertung

Referenced Papers

Journal of Parkinson's … 2024 4 Zitierungen
Journal of physiology … 2009 312 Zitierungen
Journal of the … 2007 84 Zitierungen
BioFactors (Oxford, England) 2004 48 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

Obergrenze: Well-tolerated up to 20 g/day; start low to avoid excess gas

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Beste Einnahmezeit: With meals; divide doses throughout the day

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

Bekannte Wechselwirkungen

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

Tolerierbare Höchstaufnahmemenge: Well-tolerated up to 20 g/day; start low to avoid excess gas

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Chronic Constipation

Fructooligosaccharides (FOS) für andere Beschwerden

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.